Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Hialeah, FL
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Miami Springs, FL
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Miami Springs, FL
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Miami, FL
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
North Miami, FL
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
North Miami, FL
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Orange City, FL
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Orange City, FL
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Atlanta, GA
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Suwanee, GA
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Suwanee, GA
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Quincy, MA
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Quincy, MA
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Toms River, NJ
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Toms River, NJ
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Brooklyn, NY
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
New Hyde Park, NY
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Hickory, NC
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Hickory, NC
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Raleigh, NC
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Waukesha, WI
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Waukesha, WI
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Lakewood, CA
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Lakewood, CA
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Sarasota, FL
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Charlotte, NC
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Dallas, TX
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated:  4/27/2018
Study Site
mi
from
Burgas,
Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
A 2-Month, Observational, Rollover Trial to Evaluate the Safety of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Were Previously Treated With Brexpiprazole (OPC 34712) or Placebo in a Phase 3, Double-blind Trial
Status: Enrolling
Updated: 4/27/2018
Study Site
mi
from
Burgas,
Click here to add this to my saved trials
Movement-Related Brain Networks Involved in Hand Dystonia
The Role of Cortical Coherence in Focal Hand Dystonia
Status: Enrolling
Updated:  4/28/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Movement-Related Brain Networks Involved in Hand Dystonia
The Role of Cortical Coherence in Focal Hand Dystonia
Status: Enrolling
Updated: 4/28/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Safety Study of a Gene Transfer Vector (Rh.10) for Children With Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL)
Direct CNS Administration of a Replication Deficient Adeno-associated Virus Gene Transfer Vector Serotype rh.10 Expressing the Human CLN2 cDNA to Children With Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL)
Status: Enrolling
Updated:  4/30/2018
Weill-Cornell Medical College
mi
from
New York, NY
Safety Study of a Gene Transfer Vector (Rh.10) for Children With Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL)
Direct CNS Administration of a Replication Deficient Adeno-associated Virus Gene Transfer Vector Serotype rh.10 Expressing the Human CLN2 cDNA to Children With Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL)
Status: Enrolling
Updated: 4/30/2018
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Exploratory Study to Assess Clinical Response to Gilenya® (Fingolimod) in Hispanics With RRMS
A Non-randomized, Exploratory, Study to Assess Clinical Response to Gilenya® (Fingolimod) in a Cohort of Relapsing Remitting Hispanic MS Forms
Status: Enrolling
Updated:  4/30/2018
Keck School of Medicine of the University of Southern Calfornia
mi
from
Los Angeles, CA
Exploratory Study to Assess Clinical Response to Gilenya® (Fingolimod) in Hispanics With RRMS
A Non-randomized, Exploratory, Study to Assess Clinical Response to Gilenya® (Fingolimod) in a Cohort of Relapsing Remitting Hispanic MS Forms
Status: Enrolling
Updated: 4/30/2018
Keck School of Medicine of the University of Southern Calfornia
mi
from
Los Angeles, CA
Click here to add this to my saved trials
The Use of Implementation Intentions to Increase the Appointment Attendance of OEF/OIF Veterans
The Use of Implementation Intentions to Increase the Appointment Attendance of Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans
Status: Enrolling
Updated:  4/30/2018
VA Connecticut Healthcare System
mi
from
West Haven, CT
The Use of Implementation Intentions to Increase the Appointment Attendance of OEF/OIF Veterans
The Use of Implementation Intentions to Increase the Appointment Attendance of Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans
Status: Enrolling
Updated: 4/30/2018
VA Connecticut Healthcare System
mi
from
West Haven, CT
Click here to add this to my saved trials
Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis
A Phase I/II, Open Label Study to Assess the Safety and Tolerability of VM202 in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  4/30/2018
Northwestern University
mi
from
Chicago, IL
Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis
A Phase I/II, Open Label Study to Assess the Safety and Tolerability of VM202 in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 4/30/2018
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Peripheral Sensory Input in Central Post Stroke Pain (CPSP)
How "Central" is Central Post-stroke Pain? Investigating the Role of Peripheral Sensory Input in Maintaining Central Pain
Status: Enrolling
Updated:  4/30/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Peripheral Sensory Input in Central Post Stroke Pain (CPSP)
How "Central" is Central Post-stroke Pain? Investigating the Role of Peripheral Sensory Input in Maintaining Central Pain
Status: Enrolling
Updated: 4/30/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Memory and Exercise Training Study in Older Adults With Subjective Memory Complaints
Simultaneous Aerobic Exercise and Memory Training in Older Adults With Subjective Memory Complaints
Status: Enrolling
Updated:  4/30/2018
UCLA Longevity Center
mi
from
Los Angeles, CA
Memory and Exercise Training Study in Older Adults With Subjective Memory Complaints
Simultaneous Aerobic Exercise and Memory Training in Older Adults With Subjective Memory Complaints
Status: Enrolling
Updated: 4/30/2018
UCLA Longevity Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Subcutaneous Immunoglobulin for CIDP
A Study of Subcutaneous Immunoglobulin as Chronic Treatment for Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Status: Enrolling
Updated:  4/30/2018
USF Dept of Neurology
mi
from
Tampa, FL
Subcutaneous Immunoglobulin for CIDP
A Study of Subcutaneous Immunoglobulin as Chronic Treatment for Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Status: Enrolling
Updated: 4/30/2018
USF Dept of Neurology
mi
from
Tampa, FL
Click here to add this to my saved trials
Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex
Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex
Status: Enrolling
Updated:  4/30/2018
UCLA Semel Insitute
mi
from
Los Angeles, CA
Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex
Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex
Status: Enrolling
Updated: 4/30/2018
UCLA Semel Insitute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety Study of a Gene Transfer Vector for Children With Late Infantile Neuronal Ceroid Lipofuscinosis
Administration of a Replication Deficient Adeno-associated Virus Gene Transfer Vector Expressing the Human CLN2 cDNA to the Brain of Children With Late Infantile Neuronal Ceroid Lipofuscinosis
Status: Enrolling
Updated:  4/30/2018
New York Presbyterian Hospital: Weill Medical College of Cornell University
mi
from
New York, NY
Safety Study of a Gene Transfer Vector for Children With Late Infantile Neuronal Ceroid Lipofuscinosis
Administration of a Replication Deficient Adeno-associated Virus Gene Transfer Vector Expressing the Human CLN2 cDNA to the Brain of Children With Late Infantile Neuronal Ceroid Lipofuscinosis
Status: Enrolling
Updated: 4/30/2018
New York Presbyterian Hospital: Weill Medical College of Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Open-Label Extension Study of Kuvan for Autism
Kuvan® (Sapropterin) as a Treatment for Autistic Disorder: An Open Label Extension Protocol
Status: Enrolling
Updated:  4/30/2018
The Children's Health Council
mi
from
Palo Alto, CA
Open-Label Extension Study of Kuvan for Autism
Kuvan® (Sapropterin) as a Treatment for Autistic Disorder: An Open Label Extension Protocol
Status: Enrolling
Updated: 4/30/2018
The Children's Health Council
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Delirium in the Emergency Department: Novel Screening
Delirium in the Emergency Department: Novel Screening
Status: Enrolling
Updated:  5/1/2018
Vanderbilt University Medical Center
mi
from
Nashville, TN
Delirium in the Emergency Department: Novel Screening
Delirium in the Emergency Department: Novel Screening
Status: Enrolling
Updated: 5/1/2018
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Evaluating an Online Parenting Support System Disseminated by Pediatric Practices
Evaluating an Online Parenting Support System Disseminated by Pediatric Practices
Status: Enrolling
Updated:  5/1/2018
Oregon Research Institute
mi
from
Eugene, OR
Evaluating an Online Parenting Support System Disseminated by Pediatric Practices
Evaluating an Online Parenting Support System Disseminated by Pediatric Practices
Status: Enrolling
Updated: 5/1/2018
Oregon Research Institute
mi
from
Eugene, OR
Click here to add this to my saved trials
Evaluating an Online Parenting Support System Disseminated by Pediatric Practices
Evaluating an Online Parenting Support System Disseminated by Pediatric Practices
Status: Enrolling
Updated:  5/1/2018
Seattle Children'S Research Institute
mi
from
Seattle, WA
Evaluating an Online Parenting Support System Disseminated by Pediatric Practices
Evaluating an Online Parenting Support System Disseminated by Pediatric Practices
Status: Enrolling
Updated: 5/1/2018
Seattle Children'S Research Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety Study of TPI-287 to Treat CBS and PSP
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Sequential Cohort, Dose-Ranging Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of TPI 287 in Patients With Primary Four Repeat Tauopathies: Corticobasal Syndrome or Progressive Supranuclear Palsy
Status: Enrolling
Updated:  5/1/2018
University of Alabama
mi
from
Birmingham, AL
Safety Study of TPI-287 to Treat CBS and PSP
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Sequential Cohort, Dose-Ranging Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of TPI 287 in Patients With Primary Four Repeat Tauopathies: Corticobasal Syndrome or Progressive Supranuclear Palsy
Status: Enrolling
Updated: 5/1/2018
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety Study of TPI-287 to Treat CBS and PSP
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Sequential Cohort, Dose-Ranging Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of TPI 287 in Patients With Primary Four Repeat Tauopathies: Corticobasal Syndrome or Progressive Supranuclear Palsy
Status: Enrolling
Updated:  5/1/2018
University of California at San Francisco
mi
from
San Francisco, CA
Safety Study of TPI-287 to Treat CBS and PSP
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Sequential Cohort, Dose-Ranging Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of TPI 287 in Patients With Primary Four Repeat Tauopathies: Corticobasal Syndrome or Progressive Supranuclear Palsy
Status: Enrolling
Updated: 5/1/2018
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated:  5/1/2018
The Research Center of Southern California, LLC (Assessment)
mi
from
Oceanside, CA
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated: 5/1/2018
The Research Center of Southern California, LLC (Assessment)
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated:  5/1/2018
Westview Clinical Research (Assessment)
mi
from
Placentia, CA
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated: 5/1/2018
Westview Clinical Research (Assessment)
mi
from
Placentia, CA
Click here to add this to my saved trials
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated:  5/1/2018
Ki Health Partners, LLC dba New England Institute for Clinical Research (Assessment)
mi
from
Stamford, CT
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated: 5/1/2018
Ki Health Partners, LLC dba New England Institute for Clinical Research (Assessment)
mi
from
Stamford, CT
Click here to add this to my saved trials
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated:  5/1/2018
Midtown Neurology, PC (Assessment)
mi
from
Atlanta, GA
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated: 5/1/2018
Midtown Neurology, PC (Assessment)
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated:  5/1/2018
Emory University Hospital (Surgical)
mi
from
Atlanta, GA
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated: 5/1/2018
Emory University Hospital (Surgical)
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated:  5/1/2018
Burke Rehab Center (Assessment)
mi
from
White Plains, NY
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated: 5/1/2018
Burke Rehab Center (Assessment)
mi
from
White Plains, NY
Click here to add this to my saved trials
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated:  5/1/2018
Moss Rehab (Assessment)
mi
from
Elkins Park, PA
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated: 5/1/2018
Moss Rehab (Assessment)
mi
from
Elkins Park, PA
Click here to add this to my saved trials
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated:  5/1/2018
UCLA Medical Center (Surgical/Assessment)
mi
from
Los Angeles, CA
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated: 5/1/2018
UCLA Medical Center (Surgical/Assessment)
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated:  5/1/2018
University of California, Irvine (Assessment/Surgical)
mi
from
Orange, CA
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated: 5/1/2018
University of California, Irvine (Assessment/Surgical)
mi
from
Orange, CA
Click here to add this to my saved trials
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated:  5/1/2018
Stanford Health Care (Surgical/Assessment)
mi
from
Stanford, CA
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated: 5/1/2018
Stanford Health Care (Surgical/Assessment)
mi
from
Stanford, CA
Click here to add this to my saved trials
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated:  5/1/2018
NYU Langone Medical Center (Surgical/Assessment)
mi
from
New York, NY
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated: 5/1/2018
NYU Langone Medical Center (Surgical/Assessment)
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated:  5/1/2018
University of Pittsburgh Medical Center (Surgical/Assessment)
mi
from
Pittsburgh, PA
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated: 5/1/2018
University of Pittsburgh Medical Center (Surgical/Assessment)
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated:  5/1/2018
Medical University of South Carolina (Surgical)
mi
from
Charleston, SC
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated: 5/1/2018
Medical University of South Carolina (Surgical)
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated:  5/1/2018
Hokkaido University Hospital (Surgical/Assessment)
mi
from
Sapporo,
A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)
A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Status: Enrolling
Updated: 5/1/2018
Hokkaido University Hospital (Surgical/Assessment)
mi
from
Sapporo,
Click here to add this to my saved trials